Business Description
Walgreens Boots Alliance Inc
NAICS : 446110
SIC : 5912
108 Wilmot Road, Deerfield, IL, USA, 60015
Compare
Compare
Traded in other countries / regions
WBA.Austria
•
WGBA34.Brazil
•
W8A.Germany
•
WBA.Mexico
•
WBA.Switzerland
•
0LSZ.UK
•
WBA.USA
Description
Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.42 | |||||
| Debt-to-EBITDA | 4.63 | |||||
| Interest Coverage | 7.15 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.52 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5 | |||||
| 3-Year EBITDA Growth Rate | -12.5 | |||||
| 3-Year EPS without NRI Growth Rate | -23.1 | |||||
| 3-Year FCF Growth Rate | -11.4 | |||||
| 3-Year Book Growth Rate | -0.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | -2.04 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.02 | |||||
| 9-Day RSI | 61.23 | |||||
| 14-Day RSI | 56.93 | |||||
| 6-1 Month Momentum % | -12.5 | |||||
| 12-1 Month Momentum % | -10.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.78 | |||||
| Quick Ratio | 0.43 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 30.15 | |||||
| Days Sales Outstanding | 14.73 | |||||
| Days Payable | 40.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.38 | |||||
| Dividend Payout Ratio | 0.32 | |||||
| 3-Year Dividend Growth Rate | 4.7 | |||||
| Forward Dividend Yield % | 4.91 | |||||
| 5-Year Yield-on-Cost % | 5.78 | |||||
| 3-Year Average Share Buyback Ratio | 3.1 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.82 | |||||
| Operating Margin % | 2.03 | |||||
| Net Margin % | 4 | |||||
| ROE % | 21.56 | |||||
| ROA % | 5.91 | |||||
| ROIC % | 3 | |||||
| ROC (Joel Greenblatt) % | 17.66 | |||||
| ROCE % | 9.21 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.55 | |||||
| Forward PE Ratio | 8.53 | |||||
| PE Ratio without NRI | 6.89 | |||||
| Shiller PE Ratio | 9.98 | |||||
| Price-to-Owner-Earnings | 4.83 | |||||
| PS Ratio | 0.26 | |||||
| PB Ratio | 1.34 | |||||
| Price-to-Free-Cash-Flow | 10.22 | |||||
| Price-to-Operating-Cash-Flow | 6.95 | |||||
| EV-to-EBIT | 11.26 | |||||
| EV-to-Forward-EBIT | 15.95 | |||||
| EV-to-EBITDA | 8.43 | |||||
| EV-to-Forward-EBITDA | 11.76 | |||||
| EV-to-Revenue | 0.5 | |||||
| EV-to-Forward-Revenue | 0.51 | |||||
| EV-to-FCF | 19.74 | |||||
| Price-to-Projected-FCF | 0.49 | |||||
| Price-to-Median-PS-Value | 0.44 | |||||
| Earnings Yield (Greenblatt) % | 8.88 | |||||
| Forward Rate of Return (Yacktman) % | 6.51 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 119,395.774 | ||
| EPS (TTM) (€) | 5.441 | ||
| Beta | 0.52 | ||
| Volatility % | 23.38 | ||
| 14-Day RSI | 56.93 | ||
| 14-Day ATR (€) | 0.658484 | ||
| 20-Day SMA (€) | 38.322 | ||
| 12-1 Month Momentum % | -10.66 | ||
| 52-Week Range (€) | 36.015 - 50.5 | ||
| Shares Outstanding (Mil) | 864.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Walgreens Boots Alliance Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||